Squarepoint’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
Squarepoint's PVLA Position: Q3 2026 in Review
Squarepoint sold out of Palvella Therapeutics (PVLA) in Q3 2026, closing a stake of 5,176 shares — an estimated $791K sold.
Squarepoint first reported a position in PVLA in Q4 2017 and held it in 12 quarters. The position peaked at $1.63M in Q1 2026. 196 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.
- Squarepoint reported no remaining Palvella Therapeutics position as of Q3 2026 after selling out during the quarter.
- Squarepoint sold 5,176 Palvella Therapeutics shares in Q3 2026, an estimated $791K.
- Squarepoint first reported a position in Palvella Therapeutics in Q4 2017 and held it in 12 quarters.
- Squarepoint's Palvella Therapeutics position peaked at $1.63M in Q1 2026.
- 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.